4//SEC Filing
Onaitis Matthew 4
Accession 0001209191-10-058427
CIK 0001339455other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:53 PM ET
Size
5.8 KB
Accession
0001209191-10-058427
Insider Transaction Report
Form 4
Onaitis Matthew
VP, General Counsel
Transactions
- Sale
Common Stock
2010-12-01$2.68/sh−8,468$22,724→ 64,037 total
Footnotes (2)
- [F1]This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, with the proceeds remitted to the Company to cover the taxes withheld upon the vesting of 22,500 restricted stock units on December 1, 2010.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $2.62 to $2.79 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001362822
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:53 PM ET
- Size
- 5.8 KB